AOS vs NBIX · P/E 19, rev $1.00B vs P/E 45, rev $1.77B
Smith AO Corporation (AOS) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Smith AO Corporation (AOS) is a specialty industrial machinery company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AOS revenue for 2026-06-30 was $1.00B. Net income was $124.9M. Revenue was up 6.2% from 2026-03-31 to 2026-06-30. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
AOS currently screens at market cap $9.73B and trailing P/E 19.1. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the AOS and NBIX stock pages for the full models.
Not investment advice.